This inventor holds 1 USPTO granted patent. Top assignee: Theravance Biopharma R&d IP, LLC. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovative Contributions of Guido Verniest
Introduction
Guido Verniest, an accomplished inventor based in Knesselare, Belgium, has made significant strides in the field of pharmaceutical sciences. He is recognized for his innovative work that contributes to advancements in medical treatments.
Latest Patents
Verniest holds one patent related to the formulation of a pan-JAK inhibitor. This patent encompasses pharmaceutical compositions comprising a specific chemical compound, (3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile). The patent also details methods of use and preparation, offering valuable insights into new treatment options for various conditions.
Career Highlights
Guido Verniest is currently employed at Theravance Biopharma R&D IP, LLC, where he applies his expertise to explore innovative solutions in healthcare. His contributions have had a meaningful impact on drug development and therapeutic methodologies.
Collaborations
Throughout his career, Verniest has collaborated with notable colleagues, including Bernardus Joseph Nitert and Yvonne Rosiaux. These collaborative efforts have fostered a dynamic environment that enhances research productivity and innovation.
Conclusion
In summary, Guido Verniest's inventive spirit and dedication to pharmaceutical innovation remain evident through his patent and collaborative work. His contributions at Theravance Biopharma illustrate his commitment to improving healthcare through advanced scientific research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile